Blog Articles for H.Con.Res.342 feed

H.Con.Res.342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Back to Main Bill Page

June 23, 2008 Estriol Resolution Update

The American Association for Health Freedom (AAHF) ran a full-page ad in Roll Call supporting H. Con. Res. 342 and highlighting the hypocrisy of Wyeth. The same day, hundreds of compounding pharmacists were on the Hill meeting with ...

Was this article useful? Yes or No

Source: Health Freedom Issues


June 11, 2008 Estrio resolutions

The American Association for Health Freedom (AAHF) ran a full-page ad in Roll Call supporting H. Con. Res. 342 and highlighting the hypocrisy of Wyeth. … We’re pleased to announce that the Senate has now introduced Senate Concurrent ...

Was this article useful? Yes or No

Source: ISIL Channels


May 31, 2008 Late breaking news

and eight other House members earlier this month introduced a “sense of Congress” resolution (H Con Res 342) that would ask FDA to stop its effort to ban custom-made hormones aimed at treating menopause-related symptoms that contain the ...

Was this article useful? Yes or No

Source: Female Health Problems


May 30, 2008 House Members Introduce Resolution Asking FDA To Stop Efforts To ...

and eight other House members earlier this month introduced a “sense of Congress” resolution (H Con Res 342) that would ask FDA to stop its effort to ban custom-made hormones aimed at treating menopause-related symptoms that contain the ...

Was this article useful? Yes or No

Source: Medical Health Articles


May 11, 2008 Late breaking news

The International Academy of Compounding Pharmacists joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342, a bipartisan resolution stating that “the Food and Drug Administration’s (FDA) ...

Was this article useful? Yes or No

Source: Sports News


May 09, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

of H. Con. Res. 342, a bipartisan resolution stating that “the Food and Drug Administration’s (FDA) new policy restricting women’s access to medications containing estriol does not serve the public interest” and calling on the FDA to ..

Was this article useful? Yes or No

Source: Medicine Lessons and articles


May 09, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

of H. Con. Res. 342, a bipartisan resolution stating that “the Food and Drug Administration’s (FDA) new policy restricting women’s access to medications containing estriol does not serve the public interest” and calling on the FDA to ..

Was this article useful? Yes or No

Source: General Health Articles


May 08, 2008 Congress

... his own affidavits and the information supplied by him to the passport authorities – all this basic details relating to a Congress MP kept on changing from year to year Yesterday H. Con. Res. 342 was introduced by Rep. ...

Was this article useful? Yes or No

Source: Congress


May 08, 2008 FDA Approvals - Amneal Pharmaceuticals Receives US FDA Approval ...

Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used ...

Was this article useful? Yes or No

Source: FDA News


May 08, 2008 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION STATEMENT ON “SENSE OF ...

Yesterday H. Con. Res. 342 was introduced by Rep. Mike doc (D-Ark.) and Jo Ann author (R-Mo.) anti the Food and Drug Administration’s (FDA) selection to limit Estriol (a modify of Estrogen), a compounded catecholamine activity utilised ...

Was this article useful? Yes or No

Source: Medical News


May 07, 2008 NCPA Statement on 'Sense of Congress' Resolution Opposing FDA ...

ALEXANDRIA, Va., May 7 /PRNewswire-USNewswire/ -- Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of ...

Was this article useful? Yes or No

Source: Latest Medical News from Bio-Medicine.Org


May 07, 2008 UPDATE: US HOUSE RESOLUTION DEEMS FDA’s POLICY ON ESTRIOL “NOT IN ...

H. Con. Res. 342 raises serious concern over the recent move by FDA to ban the use of estriol, and asks for its reversal. Reps. Ross and Emerson were joined by fellow Representatives: Tammy Baldwin (D-Wis.), Michael Burgess (R-Texas), ...

Was this article useful? Yes or No

Source: WorldHealth.net


May 07, 2008 NCPA statement on "sense of congress" resolution opposing FDA ...

Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration’s (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used ...

Was this article useful? Yes or No

Source: Untitled


May 07, 2008 Fda

H. Con. Res. 342 raises serious concern over the recent move . Fda Website Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration’s (FDA) decision to restrict Estriol (a form of Estrogen), a compounded ...

Was this article useful? Yes or No

Source: Fda


May 07, 2008 H.Con.Res.342 Expressing the sense of Congress that the Food and ...

Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Was this article useful? Yes or No

Source: Open Congress : Top 20 Bills Most Written...


May 07, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

MISSOURI CITY, Texas, May 7 /PRNewswire-USNewswire/ - The International Academy of Compounding Pharmacists today joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342, a bipartisan ...

Was this article useful? Yes or No

Source: Latest Medical News from Bio-Medicine.Org


May 05, 2008 Bill Action: Introduced: H.Con.Res. 342: Expressing the sense of ...

Mike Ross [D-AR] introduced H.Con.Res. 342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. ...

Was this article useful? Yes or No

Source: Active Legislation -- Tracked by govtrack.us


Information made available by:

Technorati

OpenCongress is a joint project of the Participatory Politics Foundation and the Sunlight Foundation. Questions? Comments? Contact Us

Data made available by:

Govtrack.US

Help Open Up Congress:

The OpenHouse Project